Evidence map›Paper›PMID 36548563›Full record

ArticleToxics2022

Construction of an In Vitro Air-Liquid Interface Exposure System to Assess the Toxicological Impact of Gas and Particle Phase of Semi-Volatile Organic Compounds.

Stephanie Binder, Narges Rastak, Erwin Karg, Anja Huber, Evelyn Kuhn, George C Dragan, Christian Monsé, Dietmar Breuer, Sebastiano Di Bucchianico, Mathilde N Delaval and 3 more

Open access · goldAbstract read
In one paragraph

Article in Toxics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Stephanie BinderJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Narges RastakJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Erwin KargJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Anja HuberJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Evelyn KuhnJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
George C DraganBerufsgenossenschaft Handel und Warenlogistik (BGHW), 80639 Munich, Germany.
Christian MonséInstitute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), 44789 Bochum, Germany.
Dietmar BreuerInstitute of Occupational Safety of the German Social Accident Insurance (IFA), 53757 Sankt Augustin, Germany.
Sebastiano Di BucchianicoJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.ORCID 0000-0002-6396-892X
Mathilde N DelavalJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.ORCID 0000-0002-1340-5336
Sebastian OederJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Martin SklorzJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Ralf ZimmermannJoint Mass Spectrometry Center (JMSC) at Comprehensive Molecular Analytics (CMA), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Helmholtz Zentrum München · DEInstitute for Prevention and Occupational Medicine · DEInstitut für Arbeitsschutz der Deutschen Gesetzlichen Unfallversicherung · DE

Funding

Deutsche Gesetzliche Unfallversicherung FP425
6 · The paper itself

Abstract

Anthropogenic activities and industrialization render continuous human exposure to semi-volatile organic compounds (SVOCs) inevitable. Occupational monitoring and safety implementations consider the inhalation exposure of SVOCs as critically relevant. Due to the inherent properties of SVOCs as gas/particle mixtures, risk assessment strategies should consider particle size-segregated SVOC association and the relevance of released gas phase fractions. We constructed an in vitro air-liquid interface (ALI) exposure system to study the distinct toxic effects of the gas and particle phases of the model SVOC dibutyl phthalate (DBP) in A549 human lung epithelial cells. Cytotoxicity was evaluated and genotoxic effects were measured by the alkaline and enzyme versions of the comet assay. Deposited doses were assessed by model calculations and chemical analysis using liquid chromatography tandem mass spectrometry. The novel ALI exposure system was successfully implemented and revealed the distinct genotoxic effects of the gas and particle phases of DBP. The empirical measurements of cellular deposition and the model calculations of the DBP particle phase were concordant.The model SVOC DBP showed that inferred oxidative DNA damage may be attributed to particle-related effects. While pure gas phase exposure may follow a distinct mechanism of genotoxicity, the contribution of the gas phase to total aerosol was comparably low.

Indexed as

air–liquid interface (ALI)dibutyl phthalate (DBP)gas phase (GP)particle-induced oxidative DNA damageparticle phase (PP)semi-volatile organic compounds (SVOCs)

Identifiers

PMID36548563
PMCPMC9782028
OpenAlexW4310171722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.